Telomerase, the enzyme that lengthens chromosome ends, is made of two kinds of building blocks: proteins and a piece of RNA. RNA is a close chemical relative of DNA. In telomerase, the RNA contains the template that the enzyme copies onto the chromosome end again and again.
The telomerase RNA is not ready for use when the cell first makes it. It starts as a longer precursor. This precursor has to be trimmed to the right length, folded into the right shape and joined with its protein partners. Several helper proteins accompany it step by step, much like a workpiece that passes along a production line with quality checks.
The project studies one family of such helpers, the LARP proteins. Earlier work, in which the Baumann group took part, showed how they act in human cells. One of them, LARP7, works with a partner protein to help the telomerase RNA mature. Another one, LARP3, acts as a brake. A related protein does a similar job in fission yeast. Yeast is therefore a simpler system in which ideas can be tested quickly.
People who inherit two defective copies of the LARP7 gene have Alazami syndrome. This is a very rare developmental disorder with restricted growth and intellectual disability. The blood cells of these patients also have very short telomeres. LARP7 has a second important task in the cell: it helps to control how genes are read. It is therefore not yet clear how much the telomerase problem contributes to the symptoms. This is one of the questions behind the project.
The students produce the helper proteins and the RNA in pure form and measure how firmly they bind to each other. They then change the proteins in the way they are changed in patients. In human cells grown in the laboratory, they examine which step of the production line fails and whether the telomeres become shorter.